Global Healthcare and Pharmaceutical Magazine Feature – Phillip Godden

By Protak Scientific

Phillip Godden was recently voted Pharmaceutical CEO of the Year.

In this article Phillip describes the current processes and how Enzymatic Indicators can change the face of decontamination validation, as well as what has driven him to achieve Pharmaceutical CEO of the Year.

Protak Scientific Limited is the world’s only vendor of Enzymatic Biological Indicators (EI’s), that are used as a rapid microbial method (RMM) of measuring the efficacy, distribution and performance of cold process decontamination.

ghp-august-2018-1807gh01

About Protak Scientific

I am passionate about making the world a better and safer place hence my focus on bringing the revolutionary Enzyme Indicator technology to the pharmaceutical and medical markets - a way to know decontamination results in seconds, not days. With over 16 years experience in technical, pharmaceutical and scientific sectors, I have a diverse leadership background. I have gained significant experience in, and insight into, pharmaceutical and biotech fields through roles such as Sales Director, Managing Director and CEO, in companies such as Monmouth Scientific, Howorth Air Technology, WH Leary and now Protak Scientific.

View All Posts
0